Cargando…
Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
Background: Triple-negative breast cancer (TNBC) has a poor prognosis because of frequent recurrence. Androgen receptor (AR) is involved in the pathogenesis of breast cancer, but its role is not clearly defined. The aim of this study was to explore the expression of AR and its relationship with clin...
Autores principales: | Asano, Yuka, Kashiwagi, Shinichiro, Goto, Wataru, Tanaka, Sayaka, Morisaki, Tamami, Takashima, Tsutomu, Noda, Satoru, Onoda, Naoyoshi, Ohsawa, Masahiko, Hirakawa, Kosei, Ohira, Masaichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295775/ https://www.ncbi.nlm.nih.gov/pubmed/28067809 http://dx.doi.org/10.3390/cancers9010004 |
Ejemplares similares
-
Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer
por: Asano, Yuka, et al.
Publicado: (2016) -
Multiple metastatic malignant phyllodes tumor of the breast with tonsillar metastasis: a case report
por: Sera, Tomohiro, et al.
Publicado: (2017) -
Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2017) -
Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2017) -
Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression
por: Asano, Yuka, et al.
Publicado: (2018)